Introduction   {#sec1}
==============

Isocoumarins are an important building block in synthetic medicinal chemistry because they have shown inter­esting bio­activities, for example, as anti­coagulants (Oweida *et al.*, 1990[@bb8]), as herbicides (Zhang *et al.*, 2016[@bb20]) and as insecticides (Qadeer *et al.*, 2007[@bb9]). In order to gain access to com­pounds of this type in a straightforward way, a synthetic route has been developed using reactions between 2-formyl­benzoic acid, hydrogen cyanide and anilines to yield *N*-aryldi­amino­isocoumarins (Opatz & Ferenc, 2005[@bb7]). We have reported the structures of several com­pounds of this type (Vicentes *et al.*, 2013[@bb17]) and, more recently using such com­pounds as precursors, we have developed the synthesis of a new heterocyclic system, namely fused imidazolo­isocoumarins, as part of an exploration of possible synergies between the imidazole and isocoumarin pharmacophores (Rodríguez *et al.*, 2017[@bb12]).

The bioactivity of hybrid systems containing the 1,2,3-triazole unit has been reviewed recently (Xu *et al.*, 2019[@bb19]) and, with this in mind, we have now developed an efficient synthesis of 1-aryl­isochromeno\[3,4-*d*\]\[1,2,3\]triazol-5(1*H*)-ones starting from the same *N*-aryldi­amino­isocoumarins as were used in the synthesis of imidazolo­isocoumarins (Rodríguez *et al.*, 2017[@bb12]). Thus, we now report the synthesis and spectroscopic characterization, and the mol­ecular and supra­molecular structures of four representative examples, namely, 1-phenyl­iso­chro­meno\[3,4-*d*\]\[1,2,3\]triazol-5(1*H*)-one, (I), 1-(2-methyl­phen­yl)isochromeno\[3,4-*d*\]\[1,2,3\]triazol-5(1*H*)-one, (II), 1-(3-chloro­phen­yl)isochromeno\[3,4-*d*\]\[1,2,3\]triazol-5(1*H*)-one, (III), and 1-(4-chloro­phen­yl)isochromeno\[3,4-*d*\]\[1,2,3\]triazol-5(1*H*)-one, (IV), carrying substituents at different positions in the pendent aryl group, along with those of a transesterification product, namely, methyl 2-\[4-hy­droxy-1-(2-methyl­phen­yl)-1*H*-1,2,3-tri­azol-5-yl\]benzoate, (V)[](#scheme1){ref-type="chem"}. Compounds (I)--(IV) were prepared by reaction of sodium nitrite in acetic acid with the corresponding 3-amino-4-aryl­amino-1*H*-isochromen-1-ones (**A**) (see Scheme 1); the precursors of type (**A**) having aryl = phenyl, 2-methyl­phenyl or 4-chloro­phenyl were prepared (Scheme 1) as reported previously (Rodríguez *et al.*, 2017[@bb12]), and the new analogue having aryl = 3-chloro­phenyl was prepared in the same way. The conversion of the precursors of type (**A**) to the products (I)--(IV) proceeds *via* the diazo­nium inter­mediate (**B**) (Scheme 1), which itself undergoes an intra­molecular cyclization to form the triazolo ring. It is important to stress here the necessity of using a weak acid, here acetic acid, in the diazo­tization of (**A**) to form (**B**), as isocoumarins often readily undergo ring opening in the presence of strong acids. To confirm this, a sample of com­pound (II)[](#scheme1){ref-type="chem"} was stirred in methanol in the presence of aqueous hydro­chloric acid, resulting in a qu­anti­tative conversion of (II)[](#scheme1){ref-type="chem"} to ester (V)[](#scheme1){ref-type="chem"}.

Experimental   {#sec2}
==============

Synthesis and crystallization   {#sec2.1}
-------------------------------

The known precursors of type (**A**) (see Scheme 1) having Ar = C~6~H~5~, 2-CH~3~C~6~H~4~ and 4-ClC~6~H~4~ were prepared as described previously (Rodríguez *et al.*, 2017[@bb12]); the new ana­logue having Ar = 3-ClC~6~H~4~ was prepared following the same procedure. Analytical data for 3-amino-4-(3-chloro­anilino)-1*H*-iso­chro­men-1-one: yellow solid, yield 71%, m.p. 451--452 K; IR (ATR, cm^−1^): 3456, 3319, 2922, 1701, 1592, 1474, 1306, 1089, 767, 679; NMR \[CDCl~3~, the numbering of the chloro­phenyl ring follows that for com­pound (III)\]: δ(^1^H) 8.15 (*dd*, *J* = 8.0, 0.7 Hz, 1H, H8), 7.53 (*t*, *J* = 7.6 Hz, 1H, H6), 7.20 (*t*, *J* = 7.6 Hz, 1H, H7), 7.16 (*d*, *J* = 8.1 Hz, 1H, H5), 7.10 (*t*, *J* = 8.0 Hz, 1H, H15), 6.76 (*dd*, *J* = 7.9, 1.1 Hz, 1H, H14), 6.65 (*t*, *J* = 2.0 Hz, 1H, H12), 6.56 (*dd*, *J* = 8.2, 1.6 Hz, 1H, H16), 4.85 (*s*, 1H, NH), 4.57 (*s*, 2H, NH~2~); δ(^13^C) 160.64 (CO), 154.78 (C3), 147.59 (C11), 140.40 (C4*A*), 135.65 (C13), 135.52 (C6), 130.86 (C15), 130.56 (C8), 124.23 (C7), 119.74 (C5), 119.29 (C14), 116.15 (C8A), 113.24 (C12), 111.59 (C16), 92.19 (C4); MS (EI, 70 eV): *m*/*z* (%) 285.9 (12) \[*M*\]^+^, 259.94 (31), 257.93 (100), 177.97 (16), 148.92 (20), 129.93 (21), 110.89 (17), 103.92 (17); HRMS (ESI--QTOF) found 287.0582, C~15~H~11~ ^35^ClN~2~O~2~ requires for \[*M* + H\]^+^ 287.0578.

For the synthesis of com­pounds (I)--(IV), sodium nitrite (153 mg, 2.22 mmol) was added to a suspension of the appropriate precursor (**A**) \[1.09 mmol; 275 mg for (I)[](#scheme1){ref-type="chem"}, 290 mg for (II)[](#scheme1){ref-type="chem"} and 313 mg for each of (III)[](#scheme1){ref-type="chem"} and (IV)\] in acetic acid (1.0 ml) and the resulting mixture was then stirred at ambient temperature for 5 min. The resulting solid precipitate was collected by filtration and washed with an aqueous solution of sodium hydrogen carbonate (10% *w*/*v*) and then with water. The crude solid products were purified by column chromatography on silica gel 60 (0.040--0.063 mm) using di­chloro­methane as eluent.

Analytical data for compound (I)[](#scheme1){ref-type="chem"}, colourless solid, yield 77%, m.p. 433--434 K; IR (ATR, cm^−1^): 3065, 1736, 1622, 1493, 1208, 1019, 763, 715; NMR (CDCl~3~): δ(^1^H) 8.46 (*dd*, *J* = 7.5, 1.6 Hz, 1H, H6), 7.72--7.55 (*m*, 7H, H7, H8, H12, H13, H14, H15, H16), 7.29 (*dd*, *J* = 7.8, 1.0 Hz, 1H, H9); δ(^13^C) 160.18 (CO), 154.65 (C3*A*), 136.89 (C11), 135.41 (C8), 132.84 (C6), 131.24 (C14), 130.23 (C13, C15), 129.79 (C7), 126.27 (C9*A*), 126.11 (C12, C16), 121.25 (C9), 120.57 (C9*B*), 115.26 (C5*A*); MS (EI, 70 eV): *m*/*z* (%) 262.98 (2) \[*M*\]^+^, 223.99 (35), 178.98 (100), 178.00 (29), 148.93 (36), 104.94 (23), 76.95 (35); HRMS (ESI--QTOF) found 264.0768, C~15~H~9~N~3~O~3~ requires for \[*M* + H\]^+^ 264.0768.

Analytical data for compound (II)[](#scheme1){ref-type="chem"}, colourless solid, yield 74%, m.p. 439--440 K; IR (ATR, cm^−1^): 1745, 1622, 1012, 987, 764, 680; NMR (CDCl~3~): δ(^1^H) 8.45 (*dd*, *J* = 7.1, 2.2 Hz, 1H, H8), 7.66--7.57 (*m*, 3H, H6, H7, H13), 7.55--7.48 (*m*, 2H, H14, H15), 7.46 (*dd*, *J* = 7.8, 1.6 Hz, 1H, H16), 6.92 (*dd*, *J* = 7.0, 2.1 Hz, 1H, H5), 2.10 (*s*, 3H, CH~3~); δ(^13^C) 160.22 (CO), 154.34 (C3*A*), 135.85 (C11), 135.69 (C8), 132.67 (C6), 131.89 (C14), 131.66 (C13), 129.78 (C7), 127.73 (C16), 127.38 (C15), 126.19 (C9*A*), 120.63 (C9), 120.46 (C9*B*), 115.62 (C5*A*), 17.32 (CH~3~); MS (EI, 70 eV): *m*/*z* (%) 276,97 (2) \[*M*\]^+^, 220.99 (16), 194.02 (15), 193.00 (100), 192.02 (21), 164.97 (22), 88.94 (22); HRMS (ESI--QTOF) found 278.0923, C~16~H~11~N~3~O~2~ requires for \[*M* + H\]^+^ 278.0924.

Analytical data for compound (III)[](#scheme1){ref-type="chem"}, yellow solid, yield 75%, m.p. 448--449 K; IR (ATR, cm^−1^): 3072, 2919, 2850, 1748, 1617, 1587, 1010, 885, 867, 783; NMR (CDCl~3~): δ(^1^H) 8.46 (*dd*, *J* = 7.9, 1.4 Hz, 1H, H6), 7.75--7.60 (*m*, 5H, H7, H8, H12, H14, H15), 7.56 (*ddd*, *J* = 7.7, 1.9, 1.4 Hz, 1H, H16), 7.34 (*dd*, *J* = 7.9, 0.6 Hz, 1H, H9); δ(^13^C) 159.94 (CO), 154.65 (C3*A*), 137.75 (C11), 136.03 (C13), 135.57 (C8), 132.95 (C6), 131.47 (C15), 131.22 (C14), 130.04 (C7), 126.46 (C12), 125.92 (C9*A*), 124.23 (C16), 121.20 (C9), 120.57 (C9*B*), 115.22 (C5*A*); MS (EI, 70 eV): *m*/*z* (%) 296.95 (2) \[*M*\]^+^, 214.96 (29), 213.98 (15), 212.01 (100), 177.98 (47), 150.97 (15), 74.94 (27); HRMS (ESI--QTOF) found 298.0380, C~15~H~8~ ^35^ClN~3~O~2~ requires for \[*M* + H\]^+^ 298.0378.

Analytical data for compound (IV)[](#scheme1){ref-type="chem"}, pink solid, yield 62%,, m.p. 490--492 K; IR (ATR, cm^−1^): 3087, 3066, 1740, 1620, 1457, 1217, 1013, 832, 764; NMR (CDCl~3~) δ(^1^H) 8.46 (*ddd*, *J* = 7.8, 1.5, 0.6 Hz, 1H, H6), 7.72--7.58 (*m*, 6H, H7, H8, H12, H13, H15, H16), 7.32 (*ddd*, *J* = 7.9, 1.3, 0.5 Hz, 1H, H9); δ(^13^C) 159.98 (CO), 154.69 (C3*A*), 137.45 (C11), 135.51 (C8), 135.30 (C14), 132.96 (C6), 130.53 (C13, C15), 130.00 (C7), 127.39 (C12, C16), 126.02 (C9*A*), 121.14 (C9), 120.59 (C9*B*), 115.25 (C5*A*); MS (EI, 70 eV): *m*/*z* (%) 296.93 (1.4) \[*M*\]^+^, 214.95 (31), 213.96 (15), 212.90 (100), 177.97 (39), 150.96 (14), 110.91 (13), 74.93 (25); HRMS (ESI--QTOF) found 298.0379, C~15~H~8~ ^35^ClN~3~O~2~ requires for \[*M* + H\]^+^ 298.0378.

For the conversion of com­pound (II)[](#scheme1){ref-type="chem"} into com­pound (V)[](#scheme1){ref-type="chem"}, a sample of (II)[](#scheme1){ref-type="chem"} (2.00 g, 7.22 mmol) and aqueous hydro­chloric acid (1 mol dm^−3^, 1 ml) were added to methanol (9 ml) and the resulting mixture was then stirred for 24 h at ambient temperature. The solvent was removed under reduced pressure and the resulting solid product was washed with an aqueous solution of sodium hydrogen carbonate (10% *w*/*v*) and then with water and finally dried in air to provide (V)[](#scheme1){ref-type="chem"} as a colourless solid in qu­anti­tative yield (m.p. 463--464 K). Ana­lytical data: IR (ATR, cm^−1^): 2982, 2948, 1722, 1623, 1512, 1259, 764, 713; NMR (CDCl~3~): δ(^1^H) 10.48 (*s*, 1H, OH), 7.76 (*d*, *J* = 7.7 Hz, 1H, H3), 7.51 (*td*, *J* = 7.5, 1.2 Hz, 1H, H5), 7.44 (*t*, *J* = 7.2 Hz, 1H, H4), 7.40--7.29 (*m*, 2H, H213, H214), 7.26 (*td*, *J* = 7.7, 1.1 Hz, 1H, H215), 7.23--7.16 (*m*, 2H, H6, H216), 3.67 (*s*, 3H, OCH~3~), 2.02 (*s*, 3H, CH~3~); δ(^13^C) 166.53 (CO), 155.36 (C24), 135.61 (C211), 134.49 (C214), 131.80 (C5), 131.38 (C6), 131.09 (C213), 130.85 (C25), 129.94 (C3), 129.70 (C214), 128.85 (C4), 127.39 (C216), 126.52 (C215), 126.40 (C1), 119.03 (C2), 52.12 (OCH~3~), 17.07 (CH~3~); MS (EI, 70 eV): *m*/*z* (%) 309.00 (2) \[*M*\]^+^, 239.01 (16), 237.98 (100), 219.99 (21), 193.00 (70), 164.97 (23), 90.96 (30); HRMS (ESI--QTOF) found 310.1186, C~17~H~15~N~3~O~2~ requires for \[*M* + H\]^+^ 310.1186.

Crystals of com­pounds (I)--(V) suitable for single-crystal X-ray diffraction were grown by slow evaporation, at ambient temperature and in the presence of air, of solutions in chloro­form.

Refinement   {#sec2.2}
------------

Crystal data, data collection and structure refinement details are summarized in Table 1[▸](#table1){ref-type="table"}. All H atoms were located in difference maps. H atoms bonded to C atoms were subsequently treated as riding atoms in geometrically idealized positions, with C---H = 0.95 (alkenyl and aromatic) or 0.98 Å (CH~3~) and with *U* ~iso~(H) = *kU* ~eq~(C), where *k* = 1.5 for the methyl groups, which were allowed to rotate but not to tilt, and 1.2 for all other H atoms bonded to C atoms. For the H atom bonded to an O atom in com­pound (V)[](#scheme1){ref-type="chem"}, the atomic coordinates were refined with *U* ~iso~(H) = 1.5*U* ~eq~(O), giving an O---H distance of 0.90 (2) Å. Several low-angle reflections which had been attenuated by the beam stop were omitted, *i.e.* 01 for (II)[](#scheme1){ref-type="chem"} and 02 for (IV)[](#scheme1){ref-type="chem"}; in addition, one bad outlier reflection, *i.e.* 06, was omitted from the data set for (II)[](#scheme1){ref-type="chem"} before the final refinements. For several of the refinements, the final analyses of variance showed unexpected values of *K* = \[mean(*F* ~o~ ^2^)/mean(*F* ~c~ ^2^)\] for the groups of the very weakest reflections. Thus, for (III)[](#scheme1){ref-type="chem"} and (IV)[](#scheme1){ref-type="chem"}, respectively, −0.035 and −0.125 for 312 and 289 reflections in the *F* ~c~/*F* ~c~(max) ranges 0.000--0.008 and 0.000--0.010, and for (V)[](#scheme1){ref-type="chem"}, 3.550 for 339 reflections in the *F* ~c~/*F* ~c~(max) range 0.000--0.009; these values are probably statistical artefacts.

Results and discussion   {#sec3}
========================

The constitutions of com­pounds (I)--(V) were all fully established by a combination of high-resolution mass spectrometry (HRMS), IR spectrosopy and ^1^H and ^13^C NMR spectroscopy, further confirmed by the structure analyses reported here (Figs. 1[▸](#fig1){ref-type="fig"}--5[▸](#fig2){ref-type="fig"} [▸](#fig3){ref-type="fig"} [▸](#fig4){ref-type="fig"} [▸](#fig5){ref-type="fig"}). The HRMS data for (I)--(IV) demonstrate the incorporation of an additional H atom, the IR data show the absence of an NH~2~ absorption around 3400 cm^−1^ and the ^1^H NMR spectra show the absence of signals around δ 4.5--5.0 arising from an amino group; these observations taken together confirm the conversion of the di­amino precursors of type (**A**) (Scheme 1[](#scheme1){ref-type="chem"}) into the triazolo products (I)--(IV), whose constitutions were fully confirmed by the detailed assignments of the ^1^H and ^13^C NMR spectra (see §2.1[](#sec2.1){ref-type="sec"}). Hence, the constitutions of (I)--(IV) show clearly that the anti­cipated triazolo ring formation has occurred, with the additional N atom arising from the diazo­tization process; similarly, the con­stitution of (V)[](#scheme1){ref-type="chem"} confirms the occurrence of a ring-opening transesterification process.

Aside from the orientation of the 2-methyl and 3-chloro substituents in com­pounds (II)[](#scheme1){ref-type="chem"} and (III)[](#scheme1){ref-type="chem"}, respectively, the conformations of com­pounds (I)--(IV) are fairly similar; the dihedral angles between the triazolo ring and the pendent ring (C11--C16) are 65.32 (5), 64.59 (4), 45.48 (8) and 52.32 (9)° in (I)--(IV), respectively. The mol­ecules thus exhibit no inter­nal symmetry and so are conformationally chiral in the crystalline state; the centrosymmetric space groups (Table 1[▸](#table1){ref-type="table"}) confirm that (I)--(IV) have all crystallized as conformational racemates. For all of (I)--(IV), the reference mol­ecules were selected to have the same sign for the torsion angle N2---N1---C11---C12, or N2---N1---C11---C16 in the case of (III)[](#scheme1){ref-type="chem"}. A comparison of the conformation of ester (V)[](#scheme1){ref-type="chem"} with that of its precursor (II)[](#scheme1){ref-type="chem"} (Figs. 2[▸](#fig2){ref-type="fig"} and 5[▸](#fig5){ref-type="fig"}) indicates that, in the crystalline state, there appear to have been rotations about both the bonds exocyclic to the triazolo ring in (V)[](#scheme1){ref-type="chem"}, along with a rotation about the bond linking the ester unit to the adjacent aryl ring. The significance of these differences is unclear. The bond lengths in (I)--(V) show no unusual features.

The supra­molecular assembly in com­pounds (I)--(IV) is dominated by contacts of C---H⋯N, C---H⋯O and C---H⋯π(arene) types (Table 2[▸](#table2){ref-type="table"}) and it is therefore worthwhile to specify the criteria under which such inter­actions are regarded here is structurally significant, or otherwise. Firstly, we discount all C---H⋯N and C---H⋯O contacts in which the *D*---H⋯*A* angle is less than 140°, as the inter­action energies associated with such contacts are likely to be extremely small (Wood *et al.*, 2009[@bb18]). Secondly, we discount all contacts involving methyl C---H bonds; these are not only of low acidity, but methyl groups CH~3~---*E* are generally undergoing very fast rotation about the C---*E* bonds, even in the solid state (Riddell & Rogerson, 1996[@bb10], 1997[@bb11]). In particular, for methyl groups bonded to aryl rings, as found in (II)[](#scheme1){ref-type="chem"} and (V)[](#scheme1){ref-type="chem"}, the rotation of the methyl group relative to the ring is subject to a sixfold rotation barrier, known to be in general extremely low, typically just a few J mol^−1^ rather than the more typical magnitude of a few kJ mol^−1^ (Tannenbaum *et al.*, 1956[@bb16]; Naylor & Wilson, 1957[@bb6]). Hence, there is just one significant inter­molecular C---H⋯*X* inter­action in each of (II)[](#scheme1){ref-type="chem"}, (III)[](#scheme1){ref-type="chem"} and (V)[](#scheme1){ref-type="chem"}, involving atoms C13, C16 and O24, respectively, as the donors, and two each in (I)[](#scheme1){ref-type="chem"} and (IV)[](#scheme1){ref-type="chem"}, involving as the donors C8 and C12 in (I)[](#scheme1){ref-type="chem"}, and C7 and C8 in (IV)[](#scheme1){ref-type="chem"}.

The supra­molecular assembly in com­pound (I)[](#scheme1){ref-type="chem"} is mediated by two hydrogen bonds, one each of the C---H⋯N and C---H⋯O types (Table 2[▸](#table2){ref-type="table"}). Mol­ecules which are related by an *n*-glide plane are linked by the C---H⋯N hydrogen bond to form a *C*(7) (Etter, 1990[@bb4]; Etter *et al.*, 1990[@bb5]; Bernstein *et al.*, 1995[@bb1]) chain running parallel to the \[101\] direction, while mol­ecules which are related by a 2~1~ screw axis are linked by a C---H⋯O hydrogen bond to form a *C*(9) chain running parallel to the \[010\] direction. The combination of these two chain motifs generates a sheet lying parallel to (10) and built of (28) rings (Fig. 6[▸](#fig6){ref-type="fig"}).

For com­pound (II)[](#scheme1){ref-type="chem"}, a single C---H⋯O hydrogen bond links mol­ecules which are related by a 2~1~ screw axis to form a *C*(10) chain running parallel to the \[010\] direction (Fig. 7[▸](#fig7){ref-type="fig"}), and chains of this type are linked by two π--π stacking inter­actions, both involving the fused carbocyclic ring, which together generate a π-stacked chain running parallel to \[100\] (Fig. 8[▸](#fig8){ref-type="fig"}). The combination of these two motifs generates a sheet lying parallel to (001). There is again just one hydrogen bond in the structure of com­pound (III)[](#scheme1){ref-type="chem"}, this time of the C---H⋯N type, linking mol­ecules which are related by a *c*-glide plane to form a *C*(5) chain running parallel to the \[001\] direction (Fig. 9[▸](#fig9){ref-type="fig"}), but here there are no direction-specific inter­actions between adjacent chains.

The assembly in com­pound (IV)[](#scheme1){ref-type="chem"} is built from a combination of C---H⋯O and C---H⋯π(arene) hydrogen bonds (Table 2[▸](#table2){ref-type="table"}). The C---H⋯O hydrogen bond links mol­ecules which are related by a *c*-glide plane to form a *C*(7) chain running parallel to the \[001\] direction (Fig. 10[▸](#fig10){ref-type="fig"}). By contrast, mol­ecules which are related by a 2~1~ screw axis are linked by the C---H⋯π(arene) hydrogen bond to form a chain running parallel to the \[010\] direction (Fig. 11[▸](#fig11){ref-type="fig"}), and the combination of these two chain motifs generates a sheet lying parallel to (100).

Paired O---H⋯O hydrogen bonds link inversion-related pairs of mol­ecules of (V)[](#scheme1){ref-type="chem"} to form a cyclic centrosymmetric (8) dimer (Fig. 12[▸](#fig12){ref-type="fig"}), but there are no direction-specific inter­actions between adjacent dimer units.

Thus, minor variations in the substituent on the pendent aryl ring in com­pounds (I)--(IV) are associated with significant changes in the pattern of supra­molecular assembly. Whereas for the unsubstituted parent com­pound (I)[](#scheme1){ref-type="chem"}, the mol­ecules are linked into hydrogen-bonded sheets by a combination of C---H⋯N and C---H⋯O hydrogen bonds, the sheet formation in 4-chloro derivative (IV)[](#scheme1){ref-type="chem"} is based on a combination of C---H⋯O and C---H⋯π(arene) hydrogen bonds. In each of the methyl com­pound (II)[](#scheme1){ref-type="chem"} and the 3-chloro com­pound (III)[](#scheme1){ref-type="chem"}, a single hydrogen bond, of the C---H⋯O and C---H⋯N types, respectively, links the mol­ecules into simple chains; these chains form π-stacked sheets in (II)[](#scheme1){ref-type="chem"}, but not in (III)[](#scheme1){ref-type="chem"}.

In summary, therefore, we have developed a simple and efficient route to new 1-aryl­isochromeno\[3,4-*d*\]\[1,2,3\]triazol-5(1*H*)-ones, with full spectroscopic and structural characterization of four examples, which show that small changes in substituents are associated with substantial changes in the patterns of supra­molecular aggregation, and we have demonstrated the necessity of using only a weak acid in the synthesis, along with the spectroscopic and structural characterization of a ring-opened derivative.
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======================

Crystal structure: contains datablock(s) global, I, II, III, IV, V. DOI: [10.1107/S2053229620003757/sk3747sup1.cif](https://doi.org/10.1107/S2053229620003757/sk3747sup1.cif)

Structure factors: contains datablock(s) I. DOI: [10.1107/S2053229620003757/sk3747Isup2.hkl](https://doi.org/10.1107/S2053229620003757/sk3747Isup2.hkl)

Structure factors: contains datablock(s) II. DOI: [10.1107/S2053229620003757/sk3747IIsup3.hkl](https://doi.org/10.1107/S2053229620003757/sk3747IIsup3.hkl)

Structure factors: contains datablock(s) III. DOI: [10.1107/S2053229620003757/sk3747IIIsup4.hkl](https://doi.org/10.1107/S2053229620003757/sk3747IIIsup4.hkl)

Structure factors: contains datablock(s) IV. DOI: [10.1107/S2053229620003757/sk3747IVsup5.hkl](https://doi.org/10.1107/S2053229620003757/sk3747IVsup5.hkl)

Structure factors: contains datablock(s) V. DOI: [10.1107/S2053229620003757/sk3747Vsup6.hkl](https://doi.org/10.1107/S2053229620003757/sk3747Vsup6.hkl)
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CCDC references: [1990381](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1990381), [1990380](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1990380), [1990379](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1990379), [1990378](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1990378), [1990377](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1990377)
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![The mol­ecular structure of com­pound (I)[](#scheme1){ref-type="chem"}, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level.](c-76-00446-fig1){#fig1}

![The mol­ecular structure of com­pound (II)[](#scheme1){ref-type="chem"}, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level.](c-76-00446-fig2){#fig2}

![The mol­ecular structure of com­pound (III)[](#scheme1){ref-type="chem"}, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level.](c-76-00446-fig3){#fig3}

![The mol­ecular structure of com­pound (IV)[](#scheme1){ref-type="chem"}, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level.](c-76-00446-fig4){#fig4}

![The mol­ecular structure of com­pound (V)[](#scheme1){ref-type="chem"}, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level.](c-76-00446-fig5){#fig5}

![Part of the crystal structure of com­pound (I)[](#scheme1){ref-type="chem"}, showing the formation of a hydrogen-bonded sheet of (28) rings parallel to (10). Hydrogen bonds are drawn as dashed lines and, for the sake of clarity, H atoms not involved in the motifs shown have been omitted.](c-76-00446-fig6){#fig6}

![Part of the crystal structure of com­pound (II)[](#scheme1){ref-type="chem"}, showing the formation of a hydrogen-bonded *C*(10) chain parallel to \[010\]. Hydrogen bonds are drawn as dashed lines and, for the sake of clarity, H atoms not involved in the motifs shown have been omitted.](c-76-00446-fig7){#fig7}

![Part of the crystal structure of com­pound (II)[](#scheme1){ref-type="chem"}, showing the formation of a π-stacked chain parallel to \[100\]. For the sake of clarity, H atoms have all been omitted. O atoms marked with an asterisk (\*), a hash (\#), a dollar sign (\$) or an ampersand (&) are at the symmetry positions (−*x* + 1, −*y* + 1, −*z* + 1), (−*x*, −*y* + 1, −*z* + 1), (*x* + 1, *y*, *z*) and (*x* − 1, *y*, *z*), respectively.](c-76-00446-fig8){#fig8}

![Part of the crystal structure of com­pound (III)[](#scheme1){ref-type="chem"}, showing the formation of a hydrogen-bonded *C*(5) chain parallel to \[001\]. Hydrogen bonds are drawn as dashed lines and, for the sake of clarity, H atoms not involved in the motif shown have been omitted.](c-76-00446-fig9){#fig9}

![Part of the crystal structure of com­pound (IV)[](#scheme1){ref-type="chem"}, showing the formation of a hydrogen-bonded *C*(7) chain parallel to \[001\]. Hydrogen bonds are drawn as dashed lines and, for the sake of clarity, H atoms not involved in the motif shown have been omitted.](c-76-00446-fig10){#fig10}

![Part of the crystal structure of com­pound (IV)[](#scheme1){ref-type="chem"}, showing the formation of a hydrogen-bonded chain parallel to \[010\]. Hydrogen bonds are drawn as dashed lines and, for the sake of clarity, H atoms not involved in the motif shown have been omitted.](c-76-00446-fig11){#fig11}

![Part of the crystal structure of com­pound (V)[](#scheme1){ref-type="chem"}, showing the formation of a centrosymmetric (8) dimer. Hydrogen bonds are drawn as dashed lines and, for the sake of clarity, H atoms bonded to C atoms have all been omitted. Atoms marked with an asterisk (\*) are at the symmetry position (−*x* + 1, −*y* + 1, −*z* + 1).](c-76-00446-fig12){#fig12}

###### Experimental details

###### 

For all structures: *Z* = 4. Experiments were carried out at 100 K with Mo *K*α radiation using a Bruker D8 Venture diffractometer. Absorption was corrected for by multi-scan methods (*SADABS*; Bruker, 2016[@bb2]).

                                                                             \(I\)                                  \(II\)                                 \(III\)
  -------------------------------------------------------------------------- -------------------------------------- -------------------------------------- --------------------------------------
  Crystal data                                                                                                                                             
  Chemical formula                                                           C~15~H~9~N~3~O~2~                      C~16~H~11~N~3~O~2~                     C~15~H~8~ClN~3~O~2~
  *M* ~r~                                                                    263.25                                 277.28                                 297.69
  Crystal system, space group                                                Monoclinic, *P*2~1~/*n*                Monoclinic, *P*2~1~/*n*                Monoclinic, *P*2~1~/*c*
  *a*, *b*, *c* (Å)                                                          11.6814 (5), 6.4310 (3), 16.0589 (8)   7.5676 (5), 20.2663 (14), 9.2503 (7)   11.0993 (8), 12.8996 (9), 9.2234 (6)
  β (°)                                                                      100.687 (2)                            112.957 (3)                            106.675 (2)
  *V* (Å^3^)                                                                 1185.47 (10)                           1306.33 (16)                           1265.04 (15)
  μ (mm^−1^)                                                                 0.10                                   0.10                                   0.31
  Crystal size (mm)                                                          0.20 × 0.12 × 0.06                     0.28 × 0.17 × 0.16                     0.20 × 0.12 × 0.05
                                                                                                                                                           
  Data collection                                                                                                                                          
  *T* ~min~, *T* ~max~                                                       0.936, 0.994                           0.941, 0.985                           0.895, 0.985
  No. of measured, independent and observed \[*I* \> 2σ(*I*)\] reflections   26237, 2747, 2400                      36209, 3242, 2915                      28194, 2905, 2495
  *R* ~int~                                                                  0.037                                  0.034                                  0.044
  (sin θ/λ)~max~ (Å^−1^)                                                     0.652                                  0.668                                  0.650
                                                                                                                                                           
  Refinement                                                                                                                                               
  *R*\[*F* ^2^ \> 2σ(*F* ^2^)\], *wR*(*F* ^2^), *S*                          0.036, 0.103, 1.04                     0.036, 0.098, 1.05                     0.032, 0.089, 1.08
  No. of reflections                                                         2747                                   3242                                   2905
  No. of parameters                                                          181                                    191                                    190
  H-atom treatment                                                           H-atom parameters constrained          H-atom parameters constrained          H-atom parameters constrained
  Δρ~max~, Δρ~min~ (e Å^−3^)                                                 0.31, −0.21                            0.31, −0.25                            0.32, −0.36

                                                                             \(IV\)                                 \(V\)
  -------------------------------------------------------------------------- -------------------------------------- ------------------------------------------------------------------------
  Crystal data                                                                                                      
  Chemical formula                                                           C~15~H~8~ClN~3~O~2~                    C~17~H~15~N~3~O~3~
  *M* ~r~                                                                    297.69                                 309.32
  Crystal system, space group                                                Monoclinic, *P*2~1~/*c*                Monoclinic, *P*2~1~/*c*
  *a*, *b*, *c* (Å)                                                          16.7331 (12), 5.9676 (4), 13.681 (1)   11.1518 (5), 9.3143 (4), 14.2417 (6)
  β (°)                                                                      112.820 (3)                            98.655 (2)
  *V* (Å^3^)                                                                 1259.21 (16)                           1462.46 (11)
  μ (mm^−1^)                                                                 0.31                                   0.10
  Crystal size (mm)                                                          0.25 × 0.14 × 0.11                     0.19 × 0.11 × 0.07
                                                                                                                    
  Data collection                                                                                                   
  *T* ~min~, *T* ~max~                                                       0.880, 0.967                           0.960, 0.993
  No. of measured, independent and observed \[*I* \> 2σ(*I*)\] reflections   34775, 2891, 2413                      33834, 3360, 3084
  *R* ~int~                                                                  0.056                                  0.036
  (sin θ/λ)~max~ (Å^−1^)                                                     0.650                                  0.650
                                                                                                                    
  Refinement                                                                                                        
  *R*\[*F* ^2^ \> 2σ(*F* ^2^)\], *wR*(*F* ^2^), *S*                          0.034, 0.087, 1.12                     0.042, 0.098, 1.07
  No. of reflections                                                         2891                                   3360
  No. of parameters                                                          190                                    213
  H-atom treatment                                                           H-atom parameters constrained          H atoms treated by a mixture of independent and constrained refinement
  Δρ~max~, Δρ~min~ (e Å^−3^)                                                 0.37, −0.26                            0.34, −0.22

Computer programs: *APEX3* (Bruker, 2018[@bb3]), *SAINT* (Bruker, 2018[@bb3]), *SHELXT2014* (Sheldrick, 2015*a* [@bb13]), *SHELXL2014* (Sheldrick, 2015*b* [@bb14]) and *PLATON* (Spek, 2020[@bb15]).

###### Hydrogen bonds and short inter­molecular contacts (Å, °) for com­pounds (I)--(V)

*Cg*1 and *Cg*2 represent the centroids of the C5*A*/C6--C9/C9*A* and C1--C6 rings, respectively.

  Compound   *D*---H⋯*A*              *D*---H    H⋯*A*      *D*⋯*A*       *D*---H⋯*A*
  ---------- ------------------------ ---------- ---------- ------------- -------------
  \(I\)      C8---H8⋯N3^i^            0.95       2.52       3.4641 (16)   173
             C12---H12⋯O5^ii^         0.95       2.50       3.4136 (16)   161
  \(II\)     C7---H7⋯N3^iii^          0.95       2.55       3.2770 (15)   133
             C13---H13⋯O5^iv^         0.95       2.54       3.4083 (16)   151
             C15---H15⋯O5^v^          0.95       2.48       3.2482 (16)   138
  \(III\)    C8---H8⋯N3^vi^           0.95       2.58       3.2465 (19)   127
             C16---H16⋯N2^vii^        0.95       2.56       3.500 (2)     169
  \(IV\)     C6---H6⋯O5^viii^         0.95       2.53       3.287 (3)     137
             C8---H8⋯O5^ix^           0.95       2.57       3.578 (2)     161
             C15---H15⋯N3^x^          0.95       2.52       3.271 (2)     136
             C7---H7⋯*Cg*1^xi^        0.95       2.69       3.517 (2)     146
  \(V\)      O24---H24⋯N23^xii^       0.90 (2)   1.77 (2)   2.6721 (15)   177.5 (19)
             C8---H8*A*⋯*Cg*2^xiii^   0.98       2.90       3.6605 (16)   135
             C8---H8*B*⋯*Cg*2^viii^   0.98       2.90       3.5007 (16)   120
             C8---H8*C*⋯O24^viii^     0.98       2.59       3.4004 (19)   140
             C215---H215⋯O24^xiv^     0.95       2.57       3.2972 (19)   134

Symmetry codes: (i) *x* + , −*y* + , *z* + ; (ii) −*x* + , *y* + , −*z* + ; (iii) *x* − 1, *y*, *z* − 1; (iv) −*x* + , *y* − , −*z* + ; (v) −*x* + , *y* − , −*z* + ; (vi) *x*, *y*, *z* + 1; (vii) *x*, −*y* + , *z* + ; (viii) −*x*, −*y* + 1, −*z* + 1; (ix) *x*, −*y* + , *z* − ; (x) *x*, −*y* + , *z* − ; (xi) −*x*, *y* − , −*z* + ; (xii) −*x* + 1, −*y* + 1, −*z* + 1; (xiii) −*x*, *y* − , −*z* + ; (xiv) *x*, −*y* + , *z* + .
